At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...

Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...

Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely reflecting existing concerns.

Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. With a market cap of $134.9 billion, the company offers ...

Regardless of which you choose, Pfizer's (NYSE: PFE) share price has declined during the period. Pfizer's dismal stock performance in recent years underscores the challenges the big drugmaker faces.

With a market cap of $144.8 billion, New York-based Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, develops, and markets innovative medicines and vaccines across diverse ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other safe stocks to buy for the long term in 2025. The US stock market is often regarded as one of […] ...

PFE is a Zacks Rank #3 (Hold) stock, with a Value Style Score of B and VGM Score of B. Shares are currently trading at a forward P/E of 10.7X for the current fiscal year compared to the Large Cap ...

New York-based Pfizer PFE had net income of $41 million, or 1 cent a share, for the quarter, down from $2.327 billion, or 41 cents a share, in the year-earlier period. Partner Center Most Popular ...

Pfizer has split its stock five times, the most recent of which was a 3-for-1 split in 1999. Related investing topics How to Invest in the Lego Company ...